Company / Net Debt per Share
Bristol Myers Squibb Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$16.66
FY2025
5-year range
$12.50 / $18.21
FY2021-FY2025
Trend
-8.5%
vs FY2024
Sector context
#12 of 82
Health Care
What the data says
Bristol Myers Squibb's net debt per share of $16.66 is higher than 85% of companies in the Health Care sector (FY2025). Net Debt per Share has fluctuated over the past 10 years, ranging from $-1.03 in FY2019 to $21.86 in FY2020.
Based on SEC 10-K filings.
16.66 in FY2025 with a 5-year CAGR of -5.3%. Top quartile in the Health Care sector.
Increased from $12.50 to $16.66 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +8.0%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
+21.6% above sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 8.5% year-over-year.
- Ranks #12 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2020.
- Lowest net debt per share in the period was in FY2019.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.66 | -8.5% |
| FY2024 | $18.21 | +45.7% |
| FY2023 | $12.50 | -5.4% |
| FY2022 | $13.21 | -25.6% |
| FY2021 | $17.75 | -18.8% |
| FY2020 | $21.86 | +2224.6% |
| FY2019 | -$1.03 | -588.4% |
| FY2018 | $0.21 | -89.4% |
| FY2017 | $1.98 | +2182.2% |
| FY2016 | $0.09 | -95.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026